Prestige Brands' Costs Grow With OTC Portfolio, But Retailer Orders Slow
Executive Summary
Consumer products firm's execs also expect "destocking" by drug, grocery and mass merchandise chains and other retail businesses to give way to increased purchase orders, but analysts say losing market share to e-commerce and higher freight costs could be here to stay.
You may also be interested in...
OTC Evolution For Prestige Brands Combines Near- And Long-Term Strategies
BC, Goody's, Monistat marketer boosts domestic and international OTC revenues immediately with C.B. Fleet acquisition, looks ahead to manufacturing expansion.
‘Undeniable Truth’ For US FDA Supplement Programs Director: 'So Much Noncompliance'
ODS Director Steven Tave says violative manufacturing processes and products remain common not because FDA isn’t enforcing its regulations. “I applaud those who stand behind their products, but can you stand with the same conviction behind every product on the market?” he said at regulatory summit organized by trade groups.
Return Of Buying OTC Drugs With Pre-Tax Accounts Slow To Dawn On Consumers After 10-Year Sunset
"Because of what a lot of consumers are facing right now, layoffs, furloughs, working online, they may not be aware of how this health savings account benefit can serve them at this time,” says Finance Bar CEO Marsha Barnes. CHPA is preparing digital campaign to explain that health savings, flexible spending and similar pre-tax accounts once again can be used for direct purchases of OTC drugs.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: